Phesgo and Tecentriq Performance and Approvals

Diagnostics Division sales growth by quarter Good base business growth in Q1 2023 55% 48% 31% 24% 18% 17% 9% 10% 7% 8% 4% 3% 11% 8% Diagnostics Division sales growth Base business sales growth' 0% -4% -9% -28% Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 1.2bn 1.3bn 1.0bn 1.2bn 1.9bn 1.2bn 0.6bn 0.5bn 0.3bn COVID-19 sales Growth rates and absolute values at CER (Constant exchange Rates); 1 Quarterly sales growth excluding COVID-19 sales Roche 35

View entire presentation